Patient Guide: A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 65 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04567615
Status: ACTIVE_NOT_RECRUITING
Condition: Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult, Liver Cell Carcinoma, Liver Cell Carcinoma, Adult
Phase: PHASE2

Find a Study Location Near You

This study is available at 65 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Ciudad de Buenos Aires, Buenos Aires
  • Buenos Aires, Distrito Federal
  • Rosario, Santa Fe Province
  • • And 62 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily